Complications of peripherally inserted central catheters in adults with cystic fibrosis or bronchiectasis

Journal of Vascular Access

Volumn 16, Issue 3, 2015, Pages 245-249

  Dupont, Christian ^a,b   Gouya, Hervé ^a,b   Panzo, Rozy ^a,b   Hubert, Dominique ^a,b   Correas, Jean Michel ^b,c   Agrario, Line ^a,b   Chapron, Jeanne ^a,b   Honoré, Isabelle ^a,b   Kanaan, Reem ^a,b   Legmann, Paul ^a,b   Dusser, Daniel ^a,b   Vignaux, Olivier ^a,b   Burgel, Pierre Régis ^a,b  

^a Cochin Hospital ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Catheter associated bloodstream infection; Deep vein thrombosis; Pain; Venous access

Indexed keywords

ANTIBIOTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; POLYURETHAN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CATHETER OCCLUSION; CONTROLLED STUDY; CYSTIC FIBROSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PROSPECTIVE STUDY; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN PUNCTURE; ADVERSE EFFECTS; AGE; CATHETER OBSTRUCTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; DEVICES; EQUIPMENT DESIGN; FRANCE; INDWELLING CATHETER; INTERVENTIONAL ULTRASONOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; PAIN; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CATHETER OBSTRUCTION; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CYSTIC FIBROSIS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PARIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 84930250182     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000347     Document Type: Article

References (20)

1. Chopra V, Flanders SA, Saint S. The problem with peripherally inserted central catheters. JAMA. 2012;308(15):1527-1528.
2. Chopra V, Anand S, Krein SL, Chenoweth C, Saint S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med. 2012;125(8):733-741.
3. Ajenjo MC, Morley JC, Russo AJ, et al. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients. Infect Control Hosp Epidemiol. 2011;32(2):125-130.
4. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889): 311-325.
5. Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1): i1-i58.
6. Munck A, Malbezin S, Bloch J, et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J. 2004;23(3):430-434.
7. Aitken ML, Tonelli MR. Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest. 2000;118(6):15981602.
8. Tolomeo C, Mackey W. Peripherally inserted central catheters (PICCs) in the CF population: one center’s experience. Pediatr Nurs. 2003;29(5):355-359.
9. Nash EF, Helm EJ, Stephenson A, Tullis E. Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J Vasc Interv Radiol. 2009;20(3):347-351.
10. Bui S, Babre F, Hauchecorne S, et al. Intravenous peripherallyinserted central catheters for antibiotic therapy in children with cystic fibrosis. J Cyst Fibros. 2009;8(5):326-331.
11. Dupont C, Panzo R, Silvera S, et al. Peripherally-inserted central catheter for intravenous antibiotics in adult patients with cystic fibrosis or bronchiectasis. J Cyst Fibros. 2012;11suppl 1: S131.
12. Bunting J, Slaughter RE, Masel PJ, Kroll WJ, Bell SC. Ultrasound placement of peripherally inserted central catheters (PICCs) in adults with cystic fibrosis. Thorax. 2000;55(6):535.
13. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128(2):489-495.
14. Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20(15):3276-3281.
15. Cargill J, Etherington C, Peckham D, Conway S, Denton M. Bloodstream infections in cystic fibrosis: nine years of experience in both adults and children. J Cyst Fibros. 2012;11(4): 337-339.
16. Svoboda P, Barton RP, Barbarash OL, et al. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med. 2004;32(10):1990-1996.
17. McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1)(Suppl):48S-53S.
18. Dubois J, Rypens F, Garel L, David M, Lacroix J, Gauvin F. Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ. 2007;177(10):1185-1190.
19. Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11(1):71-80.
20. Yang RY, Moineddin R, Filipescu D, et al. Increased complexity and complications associated with multiple peripherally inserted central catheter insertions in children: the tip of the iceberg. J Vasc Interv Radiol. 2012;23(3):351-357.